Loading stock data...

Rama Vision Limited

BSE: RAMAVISION

BSE
79.11 0.00 (0.00%)

Prev Close

79.11

Open Price

79.11

Volume

6

Today Low / High

79.11 / 79.11

52 WK Low / High

69.77 / 141.75

Range

75 - 83

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 79.11, reflecting a change of 0 (0%). The expected target range on the BSE is 75 - 83. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

22 Aug 79.11 0.00%
21 Aug 80.00 -1.11%
20 Aug 78.05 1.22%
19 Aug 76.12 2.50%
18 Aug 77.00 3.09%
14 Aug 79.60 -3.20%
13 Aug 78.00 2.08%
12 Aug 77.90 2.68%
11 Aug 76.00 1.37%
08 Aug 76.92 2.42%
07 Aug 77.24 -0.41%
06 Aug 79.86 -2.80%
05 Aug 79.49 0.47%
04 Aug 83.50 -4.79%
01 Aug 82.49 0.86%
31 Jul 78.00 5.49%
30 Jul 78.00 0.47%
29 Jul 77.32 0.75%
28 Jul 80.50 -3.95%

Rama Vision Limited Graph

Rama Vision Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Rama Vision Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 79.11, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 79.11 79.90 71.91 - 87.89
80.69 64.55 - 96.83
81.48 57.04 - 105.93
Bearish Scenario 79.11 78.32 70.49 - 86.15
77.53 62.02 - 93.03
76.74 53.72 - 99.76

Overview of Rama Vision Limited

ISIN

INE763B01013

Industry

Medical - Distribution

Vol.Avg

3,040

Market Cap

824,824,593

Last Dividend

0

Official Website

Visit Website

IPO Date

2000-08-25

DCF Diff

169.33

DCF

-83

Financial Ratios Every Investor Needs

Stock Rating Details for RAMAVISION

Metric Value Recommendation
Overall Rating C+ Sell
DCF Score 1 Strong Sell
ROE Score 4 Buy
ROA Score 4 Buy
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 2 Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 113.87 Cr 77.94 Cr 35.93 Cr 0.3155 0.00 Cr 0.00 Cr 21.48 Cr 2.83 Cr 2.72 7.27 Cr 0.0249
2024-03-31 89.57 Cr 62.85 Cr 26.73 Cr 0.2984 0.00 Cr 0.29 Cr 5.85 Cr 3.39 Cr 3.31 6.67 Cr 0.0378
2023-03-31 81.86 Cr 60.62 Cr 21.24 Cr 0.2595 0.00 Cr 0.28 Cr 4.26 Cr 2.54 Cr 2.53 4.71 Cr 0.0310
2022-03-31 61.74 Cr 45.67 Cr 16.08 Cr 0.2604 0.00 Cr 0.23 Cr 2.23 Cr 1.46 Cr 1.46 2.56 Cr 0.0237
2021-03-31 55.04 Cr 41.45 Cr 13.59 Cr 0.2470 0.00 Cr 0.18 Cr 2.25 Cr 0.31 Cr 0.31 2.53 Cr 0.0056

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.04 Cr 60.63 Cr 30.19 Cr 30.4362 Cr 19.94 Cr 19.91 Cr 15.62 Cr 28.65 Cr 0.00 Cr 0.00 Cr 0.01 Cr 17.9727 Cr
2024-03-31 0.01 Cr 56.78 Cr 29.18 Cr 27.6028 Cr 18.76 Cr 18.75 Cr 17.18 Cr 29.34 Cr 0.60 Cr 4.40 Cr 0.10 Cr 16.1726 Cr
2023-03-31 1.13 Cr 36.90 Cr 14.46 Cr 22.4432 Cr 9.74 Cr 8.61 Cr 15.48 Cr 12.41 Cr 0.00 Cr 0.00 Cr -0.46 Cr 10.1808 Cr
2022-03-31 4.51 Cr 32.60 Cr 13.22 Cr 19.3780 Cr 8.34 Cr 3.84 Cr 12.56 Cr 9.26 Cr 0.19 Cr 0.00 Cr -0.42 Cr 9.8121 Cr
2021-03-31 2.01 Cr 25.57 Cr 7.61 Cr 17.9512 Cr 4.38 Cr 2.36 Cr 11.24 Cr 7.11 Cr 0.15 Cr 0.00 Cr -0.05 Cr 4.6416 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -2.8033 Cr -0.9465 Cr 3.7455 Cr -4.0691 Cr -0.0043 Cr 0.0080 Cr -1.2658 Cr 2.8321 Cr -0.2058 Cr 0.0000 Cr -2.1125 Cr
2024-03-31 5.9687 Cr -18.9645 Cr 11.8765 Cr -13.2504 Cr -1.1194 Cr 0.0123 Cr -19.2191 Cr 3.3857 Cr 7.7877 Cr 0.0000 Cr 1.9693 Cr
2023-03-31 -3.6466 Cr -1.6932 Cr 1.9659 Cr -5.4187 Cr -3.3741 Cr 1.1317 Cr -1.7721 Cr 2.4939 Cr 1.3946 Cr 0.0000 Cr -2.9229 Cr
2022-03-31 0.3683 Cr -1.8448 Cr 3.9688 Cr -1.5021 Cr 2.4923 Cr 4.5058 Cr -1.8704 Cr 1.4269 Cr 3.9688 Cr 0.0000 Cr -1.3148 Cr
2021-03-31 4.0201 Cr 1.3375 Cr -3.3522 Cr 3.5569 Cr 2.0054 Cr 2.0135 Cr -0.4632 Cr 0.3112 Cr -3.3522 Cr 0.0000 Cr 3.1658 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 29.63 Cr 20.53 Cr 9.10 Cr 0.3072 5.19 Cr 0.54 Cr 0.51 1.48 Cr 0.0181
2024-12-31 29.46 Cr 20.61 Cr 8.85 Cr 0.3003 1.09 Cr 0.41 Cr 0.39 1.61 Cr 0.0139
2024-09-30 27.95 Cr 19.43 Cr 8.52 Cr 0.3048 1.42 Cr 0.69 Cr 0.66 1.95 Cr 0.0247
2024-06-30 26.83 Cr 21.12 Cr 5.71 Cr 0.2129 2.00 Cr 1.19 Cr 1.15 2.51 Cr 0.0445
2024-03-31 22.96 Cr 17.42 Cr 5.54 Cr 0.2412 1.62 Cr 0.89 Cr 0.87 2.13 Cr 0.0386

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 0.04 Cr 0.00 Cr 0.04 Cr 8.43 Cr 15.62 Cr 31.84 Cr 28.65 Cr 60.63 Cr 30.19 Cr
2024-12-31 0.00 Cr 0.00 Cr 1.54 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -29.52 Cr
2024-09-30 1.51 Cr 4.72 Cr 6.23 Cr 8.14 Cr 19.38 Cr 33.77 Cr 29.19 Cr 63.15 Cr 33.63 Cr
2024-06-30 0.00 Cr 0.00 Cr 0.30 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -27.60 Cr
2024-03-31 0.01 Cr 0.09 Cr 0.10 Cr 7.73 Cr 17.18 Cr 27.25 Cr 29.34 Cr 56.78 Cr 29.18 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 0.54 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.41 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.69 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 1.19 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 0.89 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Distribution

No stocks found in this industry.

Key Executives

Executive Business Development
Ms. Maneka Jain

Gender: female

Year Born:

Business Head, Mother & Babycare (MBC) Division
Mr. Jugesh Sahni

Gender: male

Year Born:

Whole Time Director
Mr. Udit Jain

Gender: male

Year Born: 1990

Chief Financial Officer
Mr. Kamlesh Jain

Gender: male

Year Born: 1939

Chairman & MD
Mr. Satish Jain

Gender: male

Year Born: 1954

Plant Head of Kashipur - Manufacturing
Mr. Amit Kumar Dwived

Gender: male

Year Born:

GM of Legal, Compliance Officer & Company Secretary
Mr. Raj Kumar Sehgal

Gender: male

Year Born:

Director of Marketing & Whole Time Director
Mr. Arhant Jain

Gender: male

Year Born: 1984

FAQs about Rama Vision Limited

Who is the CEO of the company?

The CEO is Satish Jain.

What is the current market price of the stock?

The current price is ₹79.11.

What is the 52-week price range?

The range is ₹69.77-141.75.

What is the market capitalization of the company?

The market capitalization is ₹82.48 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 29.40.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Rama Vision Limited (ISIN: INE763B01013) is a leading Medical - Distribution in India. With a market capitalization of ₹82.48 crores and an average daily volume of 3,040 shares, it operates in the Medical - Distribution. The company last declared a dividend of ₹0.